Recombinant human chorionic gonadotropin
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for Recombinant human chorionic gonadotropin, covering 2009-12-24 to 2021-01-25. Get the full timeline:
Most recent: Clinical Trial Update: Recombinant Human Chorionic Gonadotropin in Preventing Breast Cancer in Premenopausal Women With BRCA1 Mutations [NA]